Taiwan Semiconductor Manufacturing Company Limited (TSM)
Verdict history · TSM
Every call Verdix has made on TSM.
While a verdict holds, its return keeps accumulating from the day the call was made — it resets only when the verdict itself changes.
See methodology for how verdicts are produced. Full track record →
The panel’s case for TSM — and where they disagree.
The case for outweighs the case against at today's price.
NYSE · Information Technology / Semiconductor Foundry · 2026-08-15 · analysis, not advice
Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.
Verdict
BuyMEDIUM confidence
Why
Six distinct analytical frameworks — from discounted cash flow to scuttlebutt to macro positioning — converge on TSM as a world-class manufacturing franchise whose AI-driven growth trajectory demands attention, but they split on whether a 19x forward multiple and overbought technicals already capture that reality or leave enough room to act now versus waiting for a pullback.Level to watch
Key resistance 418.75−1.8% from 426.35
Next catalyst
Price to confirm the breakout: A daily close above $420 on expanding volume would confirm the post-correction recovery and shift the technical picture from distribution to accumulation, removing the timing objection from The Macro Opportunist and The Forensic Skeptic.The panel's take
Verdict: BUY · Conviction: MED · Last price: 426.35
The structural split is PRICE/TIMING-dominant, not BUSINESS-dominant. Technical-scout and The Macro Opportunist both want to own this business — they are simply waiting for a better entry price or a volume-confirmed breakout. That is a BUY vs WAIT split, not a BUY vs SELL split. Only The Forensic Skeptic raises a genuine BUSINESS-level objection (consensus too comfortable, growth assumptions heroic, geopolitical risk underpriced), but even he acknowledges the moat is world-class and is waiting rather than shorting. The fundamental case is overwhelming: 50%+ net margins, 55% ROIC, $80B net cash, PEG of 0.25x, beat-and-raise quarter, 15/16 analyst Buys, and broad insider buying. With The Intrinsic-Value Modeler at fair value (~$407), The Scuttlebutt Growth Investor and The GARP Operator and The Moat Compounder all Bullish, the weight of BUSINESS-conviction carries the day. The verdict tips to BUY despite the timing concerns because The Macro Opportunist and The Moat Compounder explicitly state current prices already offer a reasonable entry, and the 5:1 ratio of upside to downside at $409 (downside to $370, upside to $600) is compelling even without waiting for a better price.
Key levels
Key levels · TSM
USD · as of 2026-08-15Analyst consensus target 426.35 USD · range 426.35–426.35
Key support & resistance and analyst consensus — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.
What legendary investors think
We ran Taiwan Semiconductor Manufacturing Company Limited past a panel of 6 legendary investors' frameworks.
The panel · 6 investors
The Intrinsic-Value ModelerValuation/DCF⚫ NeutralMed
Signal: A discounted cash flow model using 30% revenue growth tapering to 15% over six years, 50% target operating margins, and a 9.0% WACC yields a fair value of $407 per share — essentially where the stock traded when modeled, confirming the market is pricing the base case with no embedded euphoria. Conviction: Conviction is capped at 70% because the valuation is acutely sensitive to the duration of hypergrowth: if AI demand proves cyclical rather than structural and growth cliffs in 2027, fair value slides to $310, while a durable extension beyond 2030 pushes it past $530.
The GARP OperatorGrowth (GARP)🟢 BullishHigh
Signal: A forward P/E of 19x against 30%+ EPS growth produces a PEG ratio of 0.25, which paired with $80 billion in net cash and 50% net margins makes this the cheapest growth story in a large-cap industrial in years. Conviction: Conviction is held back by the fact that even a perfect PEG can't neutralize a geopolitical black swan: any cross-strait shock would hit before the multiple has time to normalize, so position sizing matters more than the multiple itself.
The Scuttlebutt Growth InvestorGrowth/Management🟢 BullishHigh
Signal: Scoring a perfect 15 out of 15 on the 15-point checklist — anchored by a manufacturing moat that is 1–2 generations ahead of all competitors, customer lock-in measured in years and billions of R&D, and over 30 C-suite insider purchases since July 2026 — this is the kind of business you hold through noise, not trade around it. Conviction: Conviction sits at 87% rather than higher because the 2nm ramp introduces near-term margin dilution of 3–4 percentage points in H2 2026, and while that is strategic and temporary, its actual magnitude could surprise to the downside and create another buying opportunity.
The Moat CompounderValue/Quality/Moat🟢 BullishHigh
Signal: A 40% return on equity, 56% operating margins, and a debt-to-equity ratio of 0.15 on a balance sheet carrying $80 billion more cash than debt describe a manufacturing franchise with pricing power so durable that even the world's largest chip designers cannot credibly threaten to walk away. Conviction: Conviction is tempered because the ideal margin of safety — roughly 25–30% below intrinsic value — would require an entry near $380, and at current levels the discount is narrower than what a concentrated, long-duration position normally demands.
The Forensic SkepticContrarian/Forensic⚫ NeutralLow
Signal: Fifteen of sixteen analysts rate this a Buy, the stock dropped 20% on a beat-and-raise quarter, and the weekly MACD has bearishly crossed while monthly RSI sits overbought at 73 — a configuration that historically signals distribution, not accumulation, regardless of how strong the underlying business appears. Conviction: Conviction stays low because the PEG of 0.25 is deceptively comforting: it embeds a compound earnings growth assumption near 76% that leaves zero room for a semiconductor cycle downturn, a capex overrun, or any AI demand plateau.
The Macro OpportunistMacro/Timing🟢 BullishMed
Signal: A forward P/E of 19x on earnings compounding above 30%, set against a Fed that has paused since September 2025 with M2 stabilizing at 3.5% growth, creates a 5:1 asymmetry — downside to the $370 monthly structural support versus upside to the $600 analyst consensus target. Conviction: Conviction is held back by the weekly bearish MACD crossover and the absence of volume above $444, which means any breakout into all-time-high territory would be built on thin air and is better waited out for confirmation.
Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.
Where they agree — and where they clash
Common ground
- Every archetype agrees the manufacturing moat is extraordinary: 1–2 process generations ahead of Samsung and Intel Foundry, switching costs measured in years and billions, and a customer list (Apple, NVIDIA, AMD, Qualcomm) that cannot credibly decamp.
- Every archetype agrees the balance sheet is a fortress: $80 billion net cash, debt-to-equity of 0.15, and free cash flow sufficient to fund $62 billion in annual capex without strain.
- Every archetype agrees that 40%+ revenue growth and 50% net margins are genuine, not accounting artifacts, and that management (C.C. Wei and team) has earned trust through consistent execution and transparent communication.
- No archetype disputes that AI demand is a multi-year structural buildout, not a short-cycle spike — the debate is entirely about duration, not direction.
The real debate
- The Scuttlebutt Growth Investor and The GARP Operator see a perfect checklist score and a 0.25 PEG as unambiguous Buy signals, while The Forensic Skeptic warns that unanimous analyst bullishness and overbought technicals are the hallmarks of a crowded trade where the 'everything goes right' scenario is already priced.
- The Moat Compounder and The Macro Opportunist both want to own the business but differ on urgency: The Moat Compounder prefers to wait for a deeper discount to intrinsic value near $380, while The Macro Opportunist argues that the current 5:1 asymmetry at $409 already justifies scaling in, with a plan to add aggressively if a pullback materializes.
- The Intrinsic-Value Modeler's DCF lands at $407 — essentially fair value — creating tension with the Bullish archetypes who see 25%+ upside to Morningstar's $534 fair value estimate; the gap hinges on terminal growth assumptions and whether the AI runway extends beyond 2030.
The question it comes down to: Does the structural durability of AI-driven demand extend far enough beyond 2030 to justify paying 19x forward earnings today, or does the combination of overbought technicals, crowded consensus, and an unmodelable geopolitical tail risk argue for waiting until either the price or the narrative cracks?
The bottom line
- Price to confirm the breakout: A daily close above $420 on expanding volume would confirm the post-correction recovery and shift the technical picture from distribution to accumulation, removing the timing objection from The Macro Opportunist and The Forensic Skeptic.
- Zone to scale in aggressively: A pullback into $370–$390 — the monthly 23.6% Fibonacci retracement and the level The Moat Compounder, The Macro Opportunist, and The Intrinsic-Value Modeler all flagged — would transform this from a fair-value Buy into a high-conviction accumulation for nearly the entire panel.
- Risk to monitor: A sustained weekly close below $370 would break both the monthly structural support and the 200-day SMA, negating the Stage 2 uptrend and triggering a coordinated downgrade across price-sensitive archetypes regardless of the fundamental story.
- Next catalyst: The October 2026 earnings call will test the 2nm margin dilution guidance of 3–4 percentage points; if the actual impact comes in wider or management signals any softening in hyperscaler demand, the consensus growth trajectory unravels from the bottom up.
contact@verdixhq.com · Published 2026-08-15 · Prices as of 2026-08-15 · Time horizon: 3–12 months · No direct position held in TSM · TSM verdict history → · Methodology →
Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.
Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.